These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 20562737

  • 21. Prospective observational study of sirolimus as primary immunosuppression after renal transplantation.
    Pescovitz MD, Nezakatgoo N, Lorber MI, Nashan B, Tedesco-Silva H, Kasiske BL, de la Cruz FJ, Russ G, Campistol J, Keown PA, International Sirolimus Study Group.
    Transplantation; 2009 Oct 27; 88(8):1010-8. PubMed ID: 19855247
    [Abstract] [Full Text] [Related]

  • 22. Kidney function and morphology after short-term combination therapy with cyclosporine A, tacrolimus and sirolimus in the rat.
    Nielsen FT, Ottosen P, Starklint H, Dieperink H.
    Nephrol Dial Transplant; 2003 Mar 27; 18(3):491-6. PubMed ID: 12584269
    [Abstract] [Full Text] [Related]

  • 23. Human allograft arterial injury is ameliorated by sirolimus and cyclosporine and correlates with suppression of interferon-gamma.
    Yi T, Cuchara L, Wang Y, Koh KP, Ranjbaran H, Tellides G, Pober JS, Lorber MI.
    Transplantation; 2006 Feb 27; 81(4):559-66. PubMed ID: 16495804
    [Abstract] [Full Text] [Related]

  • 24. The novel antifibrotic agent pirfenidone attenuates the profibrotic environment generated by calcineurin inhibitors in the rat salt-depletion model.
    Brook NR, Waller JR, Bicknell GR, Nicholson ML.
    Transplant Proc; 2005 Feb 27; 37(1):130-3. PubMed ID: 15808571
    [Abstract] [Full Text] [Related]

  • 25. Usefulness of sirolimus as rescue therapy in heart transplant recipients with renal failure: analysis of the Spanish Multicenter Observational Study (RAPACOR).
    Delgado JF, Crespo MG, Manito N, Camprecios M, Rábago G, Lage E, Arizón JM, Roig E.
    Transplant Proc; 2009 Nov 27; 41(9):3835-7. PubMed ID: 19917397
    [Abstract] [Full Text] [Related]

  • 26. Conversion to sirolimus-based maintenance immunosuppression using daclizumab bridge therapy in renal transplant recipients.
    Sundberg AK, Rohr MS, Hartmann EL, Adams PL, Stratta RJ.
    Clin Transplant; 2004 Nov 27; 18 Suppl 12():61-6. PubMed ID: 15217410
    [Abstract] [Full Text] [Related]

  • 27. Is sirolimus a safe alternative to reduce or eliminate calcineurin inhibitors in chronic allograft nephropathy in kidney transplantation?
    Lai WJ, Chiang YJ, Chen Y, Chu SH.
    Transplant Proc; 2004 Sep 27; 36(7):2056-7. PubMed ID: 15518744
    [Abstract] [Full Text] [Related]

  • 28. Conversion to sirolimus with calcineurin inhibitor elimination vs. dose minimization and renal outcome in heart and lung transplant recipients.
    Demirjian S, Stephany B, Abu Romeh IS, Boumitri M, Yamani MH, Poggio ED.
    Clin Transplant; 2009 Sep 27; 23(3):351-60. PubMed ID: 19208105
    [Abstract] [Full Text] [Related]

  • 29. Sirolimus-based immunosuppressive therapy in liver transplant recipient with tacrolimus-related chronic renal insufficiency.
    Yang YJ, Chen DZ, Li LX, Kou JT, Lang R, Jin ZK, Han DD, He Q.
    Transplant Proc; 2008 Jun 27; 40(5):1541-4. PubMed ID: 18589147
    [Abstract] [Full Text] [Related]

  • 30. Treatment with sirolimus is associated with less weight gain after kidney transplantation.
    Diekmann F, Campistol JM, Rovira J, Budde K, Neumayer HH, Oppenheimer F, Flechner SM.
    Transplantation; 2013 Sep 15; 96(5):480-6. PubMed ID: 23912169
    [Abstract] [Full Text] [Related]

  • 31. Improved 24-hour blood pressure control with sirolimus versus calcineurin inhibitor based immunosuppression in renal transplant recipients.
    Steigerwalt SP, Brar N, Dhungel A, Butcher D, Steigerwalt S, El-Ghouroury M, Provenzano R.
    Transplant Proc; 2009 Dec 15; 41(10):4184-7. PubMed ID: 20005365
    [Abstract] [Full Text] [Related]

  • 32. Expression of transforming growth factor-beta-inducible gene-h3 in normal and cyclosporine-treated rat kidney.
    Sun BK, Li C, Lim SW, Jung JY, Lee SH, Kim IS, Kim YS, Kim J, Bang BK, Yang CW.
    J Lab Clin Med; 2004 Mar 15; 143(3):175-83. PubMed ID: 15007308
    [Abstract] [Full Text] [Related]

  • 33. Protocol conversion from a calcineurin inhibitor based therapy to sirolimus.
    Oberbauer R.
    Transplantation; 2009 Apr 27; 87(8 Suppl):S7-10. PubMed ID: 19384186
    [Abstract] [Full Text] [Related]

  • 34. Inhibitory effect of tea polyphenols on transforming growth factor-beta1 expression in rat with cyclosporine A-induced chronic nephrotoxicity.
    Shi SH, Zheng SS, Jia CK, Zhu YF, Xie HY.
    Acta Pharmacol Sin; 2004 Jan 27; 25(1):98-103. PubMed ID: 14704129
    [Abstract] [Full Text] [Related]

  • 35. Prograf produces a molecular environment favoring antifibrosis, an effect reversed by the addition of rapamune.
    Brook NR, Waller JR, Bicknell GR, Nicholson ML.
    Transplant Proc; 2005 Jan 27; 37(1):148-9. PubMed ID: 15808577
    [Abstract] [Full Text] [Related]

  • 36. Klotho gene, phosphocalcic metabolism, and survival in dialysis.
    Torres PU, Prié D, Beck L, De Brauwere D, Leroy C, Friedlander G.
    J Ren Nutr; 2009 Jan 27; 19(1):50-6. PubMed ID: 19121771
    [Abstract] [Full Text] [Related]

  • 37. Long-term improvement in renal function with sirolimus after early cyclosporine withdrawal in renal transplant recipients: 2-year results of the Rapamune Maintenance Regimen Study.
    Oberbauer R, Kreis H, Johnson RW, Mota A, Claesson K, Ruiz JC, Wilczek H, Jamieson N, Henriques AC, Paczek L, Chapman J, Burke JT, Rapamune Maintenance Regimen Study Group.
    Transplantation; 2003 Jul 27; 76(2):364-70. PubMed ID: 12883194
    [Abstract] [Full Text] [Related]

  • 38. Role of endothelin-1 and nitric oxide bioavailability in transplant-related vascular injury: comparative effects of rapamycin and cyclosporine.
    Ramzy D, Rao V, Tumiati LC, Xu N, Miriuka S, Delgado D, Ross HJ.
    Circulation; 2006 Jul 04; 114(1 Suppl):I214-9. PubMed ID: 16820575
    [Abstract] [Full Text] [Related]

  • 39. Early and delayed effects of AST-120 on chronic cyclosporine nephropathy.
    Kim SH, Ghee JY, Piao S, Han DH, Song JH, Yoon HE, Choi BS, Kim J, Nishijima F, Obara K, Ishikawa N, Yang CW.
    Nephrol Dial Transplant; 2011 May 04; 26(5):1502-15. PubMed ID: 20947537
    [Abstract] [Full Text] [Related]

  • 40. Absence of proteinuria predicts improvement in renal function after conversion to sirolimus-based immunosuppressive regimens in lung transplant survivors with chronic kidney disease.
    Stephany BR, Boumitri M, Budev M, Alao B, Poggio ED.
    J Heart Lung Transplant; 2009 Jun 04; 28(6):564-71. PubMed ID: 19481016
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.